- Home
- KLXE vs RNXT Comparison
KLXE vs RNXT Comparison
Compare KLXE & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- RNXT
- Stock Information
- Founded
- KLXE 2018
- RNXT 2012
- Country
- KLXE United States
- RNXT United States
- Employees
- KLXE N/A
- RNXT N/A
- Industry
- KLXE Oilfield Services/Equipment
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- RNXT Health Care
- Exchange
- KLXE Nasdaq
- RNXT Nasdaq
- Market Cap
- KLXE 35.8M
- RNXT 44.6M
- IPO Year
- KLXE N/A
- RNXT 2021
- Fundamental
- Price
- KLXE $1.72
- RNXT $1.40
- Analyst Decision
- KLXE Hold
- RNXT Strong Buy
- Analyst Count
- KLXE 1
- RNXT 2
- Target Price
- KLXE $4.50
- RNXT $7.00
- AVG Volume (30 Days)
- KLXE 158.8K
- RNXT 210.6K
- Earning Date
- KLXE 05-08-2025
- RNXT 05-15-2025
- Dividend Yield
- KLXE N/A
- RNXT N/A
- EPS Growth
- KLXE N/A
- RNXT N/A
- EPS
- KLXE N/A
- RNXT N/A
- Revenue
- KLXE $688,600,000.00
- RNXT $240,000.00
- Revenue This Year
- KLXE N/A
- RNXT $3,927.91
- Revenue Next Year
- KLXE $3.97
- RNXT $219.75
- P/E Ratio
- KLXE N/A
- RNXT N/A
- Revenue Growth
- KLXE N/A
- RNXT N/A
- 52 Week Low
- KLXE $1.51
- RNXT $0.75
- 52 Week High
- KLXE $7.66
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- KLXE 37.57
- RNXT 78.13
- Support Level
- KLXE $1.73
- RNXT $1.17
- Resistance Level
- KLXE $1.98
- RNXT $1.30
- Average True Range (ATR)
- KLXE 0.20
- RNXT 0.08
- MACD
- KLXE -0.00
- RNXT 0.02
- Stochastic Oscillator
- KLXE 5.41
- RNXT 100.00
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.